Vaccines, Vaccination and Immunization

mRNA and Nucleic Acid Vaccines

This session will examine developments in mRNA, DNA, and other nucleic-acid vaccine technologies. Discussions will cover antigen design, delivery systems, lipid nanoparticles, formulation technologies, immune responses, manufacturing, and clinical development. Researchers will present emerging findings on the application of nucleic-acid platforms to infectious diseases and other potential indications. Particular attention will be given to opportunities for rapid vaccine design and adaptation in response to emerging pathogens. Speakers may also address challenges related to stability, storage, manufacturing capacity, regulatory evaluation, and global accessibility. The session will bring together molecular biologists, immunologists, vaccine developers, clinicians, biotechnology researchers, and pharmaceutical professionals to exchange knowledge about the evolving role of nucleic-acid technologies in modern vaccine research and future immunization strategies.